United States · 
Who invested in Clarametyx Biosciences?
Clarametyx Biosciences's investors include Rev1 Ventures.
20252026
?Venture$850KSeries A
United States · Series A startup
Who invested in Clarametyx Biosciences
Funding summaryUpdated 26 Oct 2026
$850Kraised across 2 rounds since 2025, from 2 sources
- Latest round
- Series A, $850KOct 2025
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture Jan 2025
- Biggest round
- $850K Series A · Oct 2025
- Between rounds
- 9 months from the last two
The rounds
- Oct 2025
- Jan 2025
Founders and team
From Clarametyx Biosciences's own website and the SEC filings it signed: 3 on the team.
- David RichardsChief Executive Officer
- Karen MenaVice President, Clinical Operations
- Robin Joy EdmondsDirector, Project Operations
On the board, as filediChuck G. BramlageLarry G. EdwardsMichael G. LaymanMichael TriplettPeter G. KleinhenzWayne G. EmbreeWilliam G. Baumel
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Clarametyx Biosciences
How much has Clarametyx Biosciences raised?
Clarametyx Biosciences has raised $850K across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.
When did Clarametyx Biosciences last raise?
Clarametyx Biosciences's most recent round was a Series A of $850K in Oct 2025.
What was Clarametyx Biosciences's biggest round?
Its most recent round, $850K in Oct 2025, is also its largest on record.
Who backed Clarametyx Biosciences first?
Clarametyx Biosciences's first round on record, in Jan 2025, was backed by Rev1 Ventures.
What stage is Clarametyx Biosciences at?
Clarametyx Biosciences's latest named round is a Series A, in Oct 2025.
Where is Clarametyx Biosciences based?
Clarametyx Biosciences is based in the United States.
Companies like Clarametyx Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.